L. Ellgaard and A. Helenius, Quality control in the endoplasmic reticulum, Nature Reviews Molecular Cell Biology, vol.418, issue.3, pp.181-91, 2003.
DOI : 10.1038/nrm1052

T. Anelli and R. Sitia, Protein quality control in the early secretory pathway, The EMBO Journal, vol.18, issue.2, pp.315-342, 2008.
DOI : 10.1038/sj.emboj.7601974

A. Arrigo, Chaperons moléculaires et repliement des protéines, Med Sci, vol.21, pp.619-644, 2005.

B. Tsai, Y. Ye, and T. Rapoport, Retro-translocation of proteins from the endoplasmic reticulum into the cytosol, Nature Reviews Molecular Cell Biology, vol.1, issue.4, pp.246-55, 2002.
DOI : 10.1038/nrm780

F. Cohen and J. Kelly, Therapeutic approaches to protein-misfolding diseases, Nature, vol.426, issue.6968, pp.905-914, 2003.
DOI : 10.1038/nature02265

T. Chaudhuri and S. Paul, Protein-misfolding diseases and chaperone-based therapeutic approaches, FEBS Journal, vol.94, issue.9364, pp.1331-1380, 2006.
DOI : 10.1016/S0165-6147(00)01575-3

J. Riordan, The Cystic Fibrosis Transmembrane Conductance Regulator, Annual Review of Physiology, vol.55, issue.1, pp.609-639, 1993.
DOI : 10.1146/annurev.ph.55.030193.003141

B. Kerem, J. Rommens, J. Buchanan, and D. Markiewicz, Identification of the cystic fibrosis gene: genetic analysis, Science, vol.245, issue.4922, pp.1073-1080, 1989.
DOI : 10.1126/science.2570460

D. Germain, J. La-maladie-de-fabry-fan, S. Ishii, N. Asano, and Y. Suzuki, de la découverte des lysosomes à l'avènement de la thérapeutique Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor, Med Sci Nature Med, vol.21, issue.5, pp.5-7, 1999.

G. Grabowski, Gaucher Disease, Adv Hum Genet, vol.21, pp.377-441, 1993.
DOI : 10.1007/978-1-4615-3010-7_5

A. Sawkar, W. Cheng, E. Beutler, and C. Wong, Nonlinear partial differential equations and applications: Chemical chaperones increase the cellular activity of N370S ??-glucosidase: A therapeutic strategy for Gaucher disease, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15428-15461, 2002.
DOI : 10.1073/pnas.192582899

P. Conn, . Ulloa-aguirre, J. Ito, and J. Janovick, G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo, Pharmacological Reviews, vol.59, issue.3, pp.225-50, 2007.
DOI : 10.1124/pr.59.3.2

H. Mendes, J. Van-der-spuy, J. Chapple, and M. Cheetham, Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy, Trends in Molecular Medicine, vol.11, issue.4, pp.177-85, 2005.
DOI : 10.1016/j.molmed.2005.02.007

J. Morello and D. Bichet, Nephrogenic Diabetes Insipidus, Annual Review of Physiology, vol.63, issue.1, pp.607-637, 2001.
DOI : 10.1146/annurev.physiol.63.1.607

P. Conn and J. Janovick, Drug development and the cellular quality control system, Trends in Pharmacological Sciences, vol.30, issue.5, pp.228-261, 2009.
DOI : 10.1016/j.tips.2009.02.002

S. Sato, C. Ward, M. Krouse, and J. Wine, Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation, Journal of Biological Chemistry, vol.271, issue.2, pp.635-673, 1996.
DOI : 10.1074/jbc.271.2.635

M. Oueslati, R. Hermosilla, E. Schönenberger, and V. Oorschot, Rescue of a Nephrogenic Diabetes Insipidus-causing Vasopressin V2 Receptor Mutant by Cell-penetrating Peptides, Journal of Biological Chemistry, vol.282, issue.28, pp.20676-85, 2007.
DOI : 10.1074/jbc.M611530200

T. Loo and D. Clarke, Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators, Journal of Biological Chemistry, vol.272, issue.2, pp.709-721, 1997.
DOI : 10.1074/jbc.272.2.709

J. Morello, A. Salahpour, A. Laperrière, and V. Bernier, Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants, Journal of Clinical Investigation, vol.105, issue.7, pp.887-95, 2000.
DOI : 10.1172/JCI8688

V. Bernier, J. Morello, A. Zarruk, and N. Debrand, Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus, Journal of the American Society of Nephrology, vol.17, issue.1, pp.232-275, 2006.
DOI : 10.1681/ASN.2005080854

F. Jean-alphonse, S. Perkovska, M. Frantz, and T. Durroux, Biased Agonist Pharmacochaperones of the AVP V2 Receptor May Treat Congenital Nephrogenic Diabetes Insipidus, Journal of the American Society of Nephrology, vol.20, issue.10, pp.2190-203, 2009.
DOI : 10.1681/ASN.2008121289
URL : https://hal.archives-ouvertes.fr/inserm-00421838

J. Robben, M. Sze, N. Knoers, and P. Deen, Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus, AJP: Renal Physiology, vol.292, issue.1, pp.253-260, 2007.
DOI : 10.1152/ajprenal.00247.2006

T. Li, M. Sandberg, B. Pawlyk, and B. Rosner, Effect of vitamine A supplementation on rhodopsin mutants T17M and P347S in transgenic mice and in cell cultures, pp.11933-11971, 1998.

U. Petäjä-repo, M. Hogue, S. Bhalla, and A. Laperrière, Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation, The EMBO Journal, vol.21, issue.7, pp.1628-1665, 2002.
DOI : 10.1093/emboj/21.7.1628

J. Janovick, G. Maya-nunez, A. Ulloa-aguirre, and I. Huhtaniemi, Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine, Molecular and Cellular Endocrinology, vol.298, issue.1-2, pp.84-88, 2009.
DOI : 10.1016/j.mce.2008.09.015

R. Carrell, D. Lomas, S. Sidhar, R. Foreman, B. Foster et al., ??1-Antitrypsin Deficiency, Chest, vol.110, issue.6, pp.243-290, 1996.
DOI : 10.1378/chest.110.6_Supplement.243S

F. Toledo, O. Bluteau, and I. Simeonova, R??activation de p53 dans les tumeurs : une strat??gie antitumorale prometteuse, m??decine/sciences, vol.23, issue.6-7, pp.565-67, 2007.
DOI : 10.1051/medsci/20072367565

C. Lam, J. Xie, K. To, and H. Ng, A frequent activated smoothened mutation in sporadic basal cell carcinomas, Oncogene, vol.18, issue.3, pp.833-869, 1999.
DOI : 10.1038/sj.onc.1202360

C. Partridge, D. Beech, and A. Sivaprasadarao, Identification and Pharmacological Correction of a Membrane Trafficking Defect Associated with a Mutation in the Sulfonylurea Receptor Causing Familial Hyperinsulinism, Journal of Biological Chemistry, vol.276, issue.38, pp.35947-52, 2001.
DOI : 10.1074/jbc.M104762200

E. Pratt, F. Yan, J. Gay, and C. Stanley, Sulfonylurea Receptor 1 Mutations That Cause Opposite Insulin Secretion Defects with Chemical Chaperone Exposure, Journal of Biological Chemistry, vol.284, issue.12, pp.7951-59, 2009.
DOI : 10.1074/jbc.M807012200

B. Kim, K. Smith, C. Meagher, and M. Petrisd, A Conditional Mutation Affecting Localization of the Menkes Disease Copper ATPase. SUPPRESSION BY COPPER SUPPLEMENTATION, Journal of Biological Chemistry, vol.277, issue.46, pp.44079-84, 2002.
DOI : 10.1074/jbc.M208737200

X. Liu, P. Garriga, and H. Khorana, Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa., Proceedings of the National Academy of Sciences, vol.93, issue.10, pp.4554-59, 1996.
DOI : 10.1073/pnas.93.10.4554

S. Fuchs, J. Amiel, S. Claudel, and S. Lyonnet, Functional characterization of three mutations of the endothelin B receptor gene in patients with Hirshsprung's disease : evidence for selective loss of Gi coupling, Mol Med, vol.7, pp.115-139, 2001.

C. Lubrano-berthelier, B. Dubern, J. Lacorte, and F. Picard, Melanocortin 4 Receptor Mutations in a Large Cohort of Severely Obese Adults: Prevalence, Functional Classification, Genotype-Phenotype Relationship, and Lack of Association with Binge Eating, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.5, pp.1811-1829, 2006.
DOI : 10.1210/jc.2005-1411
URL : https://hal.archives-ouvertes.fr/hal-00427994

A. Clark, L. Metherell, M. Cheetham, and A. Huebner, Inherited ACTH insensitivity illuminates the mechanisms of ACTH action, Trends in Endocrinology & Metabolism, vol.16, issue.10, pp.451-57, 2005.
DOI : 10.1016/j.tem.2005.10.006

M. Samson, F. Libert, B. Doranz, and J. Rucker, Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, Nature, vol.382, issue.6593, pp.722-747, 1996.
DOI : 10.1038/382722a0

J. Tfelt-hansen and E. Brown, THE CALCIUM-SENSING RECEPTOR IN NORMAL PHYSIOLOGY AND PATHOPHYSIOLOGY: A Review, Critical Reviews in Clinical Laboratory Sciences, vol.111, issue.2, pp.35-70, 2007.
DOI : 10.1172/JCI9038

H. Biebermann, T. Schoneberg, H. Krude, and G. Schultz, Mutations of the Human Thyrotropin Receptor Gene Causing Thyroid Hypoplasia and Persistent Congenital Hypothyroidism, Journal of Clinical Endocrinology & Metabolism, vol.82, issue.10, pp.3471-80, 1997.
DOI : 10.1210/jc.82.10.3471

A. Themmen, J. Martens, and H. Brunner, Activating and inactivating mutations in LH receptors, Molecular and Cellular Endocrinology, vol.145, issue.1-2, pp.137-179, 1998.
DOI : 10.1016/S0303-7207(98)00180-4

K. Aittomäki, L. Lucena, P. Pakarinen, and P. Sistonen, Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure, Cell, vol.82, issue.6, pp.959-68, 1995.
DOI : 10.1016/0092-8674(95)90275-9

K. Beaumont, R. Newton, D. Smit, and J. Leonard, Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk, Human Molecular Genetics, vol.14, issue.15, pp.2145-54, 2005.
DOI : 10.1093/hmg/ddi219

S. Noorwez, R. Malhotra, J. Mcdowell, and K. Smith, Retinoids Assist the Cellular Folding of the Autosomal Dominant Retinitis Pigmentosa Opsin Mutant P23H, Journal of Biological Chemistry, vol.279, issue.16, pp.16278-84, 2004.
DOI : 10.1074/jbc.M312101200

J. Sacchetini and J. Kelly, THERAPEUTIC STRATEGIES FOR HUMAN AMYLOID DISEASES, Nature Reviews Drug Discovery, vol.1, issue.4, pp.267-75, 2002.
DOI : 10.1038/35089090

H. Kobayashi, K. Ogawa, R. Yao, and O. Lichtarge, -Adrenoceptor Dimerization and Trafficking by Pharmacological Chaperones, Traffic, vol.13, issue.8, pp.1019-1052, 2009.
DOI : 10.1111/j.1600-0854.2009.00932.x
URL : https://hal.archives-ouvertes.fr/hal-00409826

B. Stanton and L. Peng, Small-molecule modulators of the Sonic Hedgehog signaling pathway, Mol. BioSyst., vol.106, issue.1, pp.44-54, 2010.
DOI : 10.1039/B910196A

A. Pey, M. Ying, N. Cremades, and A. Velazquez-campoy, Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria, Journal of Clinical Investigation, vol.118, issue.8, pp.2858-67, 2008.
DOI : 10.1172/JCI34355

N. Asano, S. Ishii, H. Kizu, and K. Ikeda, In vitro inhibition and intracellular enhancement of lysosomal ??-galactosidase???A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives, European Journal of Biochemistry, vol.262, issue.13, pp.4179-86, 2000.
DOI : 10.1046/j.1432-1327.2000.01457.x

C. Korth, B. May, F. Cohen, and S. Prusiner, Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease, Proc. Natl. Acad. Sci. USA, pp.9836-9877, 2001.
DOI : 10.1073/pnas.161274798

E. Sigurdsson, B. Permanne, C. Soto, and T. Wisniewski, In Vivo Reversal of Amyloid-?? Lesions in Rat Brain, Journal of Neuropathology & Experimental Neurology, vol.59, issue.1, pp.11-17, 2000.
DOI : 10.1093/jnen/59.1.11

V. Heiser, E. Scherzinger, A. Boeddrich, and E. Nordhoff, Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy, Proc. Natl. Acad. Sci. USA, pp.6739-6783, 2000.
DOI : 10.1073/pnas.110138997